Hipromelosa

Quick links to important sections

Hipromelosa

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hipromelosa

Quick Facts

Property Description
Active Ingredient Hypromellose (Hydroxypropyl Methylcellulose, HPMC)
Form Ophthalmic Solution (Eye Drops)
Pharmacological Class Ophthalmic Lubricant, Ocular Demulcent
Common Use (General) Relief of eye dryness and surface irritation
Origin Semi-synthetic polymer (Cellulose derivative)

What is Hipromelosa and its Pharmacological Class?

Hipromelosa is a medicinal product containing the active substance Hypromellose (INN: Hydroxypropyl Methylcellulose, HPMC). It is classified as an Ophthalmic Lubricant and Ocular Demulcent, which indicates its primary function is to provide physical comfort and moisture, not active chemical intervention. This polymer is clinically acknowledged in pharmacological studies for its ability to increase viscosity and stabilize the tear film. Hypromellose preparations are widely used to moisten and protect the eye surface. This confirms that the medicine’s primary function is to ease the physical discomfort caused by insufficient moisture.

Composition, Form, and Origin of Hypromellose

The drug is supplied as a sterile, water-based solution, known as Ophthalmic Solution or eye drops, intended for Ocular Route of Administration. Hypromellose is a semi-synthetic polymer, derived through the chemical modification of cellulose, a natural substance. This process results in a compound that is highly biocompatible for the sensitive eye tissues, a key feature in products designed for regular eye relief. Hypromellose is dissolved in an Aqueous Solution base, ensuring the preparation is water-soluble and easily spread across the eye.

What is the General Purpose of Ophthalmic Lubricants?

The general purpose of using Hipromelosa is to provide external hydration and lubrication by reinforcing the eye's natural moisture layer, typically used for over-the-counter management of common dryness. Hypromellose works as a viscoelastic agent, which physically thickens the tear film and slows the rate at which tears evaporate. This prolonged wetting action, which mimics the protective function of the natural tear film, broadly helps to mitigate non-specific symptoms such as burning, grittiness, and the physical sensation of irritation that arise from a deficient tear layer.

Regulatory References

  1. National Institutes of Health

What side effects are possible with Hipromelosa?

Possible Side Effects and Safety Information

Hipromelosa (also known as Hydroxypropyl methylcellulose) is an inert substance primarily used as an ophthalmic demulcent, and its safety profile is characterized by a low risk of systemic effects due to negligible absorption. Adverse reactions are predominantly local and temporary, related to the application site.


Adverse Reaction Profile

Adverse reactions are almost exclusively Ocular Disorders, involving the eye and surrounding tissues.

Classification Adverse Reactions
Common Temporary blurred vision immediately following instillation.
Not Known Mild stinging, foreign body sensation, eye irritation, eye pain, and ocular hyperaemia (redness of the eye).

Serious or Clinically Significant Reactions: While rare, immediate medical attention is necessary if symptoms of a severe allergic reaction (e.g., rash, swelling of the face/tongue, severe dizziness, or trouble breathing) occur. Persistent symptoms such as continued eye pain, changes in vision, or worsening redness/irritation should prompt consultation with a healthcare professional.


Safety Restrictions and Limitations

  • Contraindication: Hipromelosa is contraindicated in individuals with known hypersensitivity to the active substance or any of the excipients.
  • Contact Lenses: Formulations containing the preservative benzalkonium chloride must not be used while wearing soft contact lenses as the preservative may accumulate. Lenses should be removed prior to application and reinserted at least 15 minutes later.
  • Corneal Health: Caution is advised in patients with compromised corneal surfaces or pre-existing severe dry eye conditions, particularly with prolonged use of preserved solutions.
  • Driving/Operating Machinery: Due to the risk of transient blurred vision immediately after application, individuals should not drive or operate complex machinery until their vision has cleared completely.
  • Pregnancy and Breastfeeding: Systemic risk is considered low to none due to the inert nature and negligible absorption; however, usage should be based on clinical need and consultation.

The safety profile indicates that the primary risks are mild, transient discomforts upon use. Serious adverse events are rare, with the most important restrictions revolving around the presence of the preservative in certain formulations and the temporary visual disturbance post-application.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Hipromelosa (Hypromellose) Ophthalmic Solution is defined by its negligible toxic risk. This medicine is an inert, semi-synthetic polymer that is not absorbed systemically, meaning no toxic effects are expected from ocular overuse.

Documented Overdose Outcomes

Exposure Scenario Regulatory Statement
Ocular Overdose No toxic effects are anticipated due to the inert nature of the preparation.
Systemic Risk Not applicable; the substance has no pharmacological activity and is not absorbed systemically.

Emergency Actions Mandated by Regulators

While systemic toxicity is not anticipated, regulatory guidance on accidental exposure must be followed.

Immediate action is required if the medicine is swallowed:

  • Contact a Poison Control Center right away after accidental ingestion.
  • Seek immediate medical attention (e.g., call 911 or emergency services) if the person exhibits serious signs, such as trouble breathing or passing out.

If symptoms relate to the eye, the required action is consultation. Use must be discontinued and a healthcare professional consulted if eye pain, continued redness, changes in vision, or irritation persists or worsens, as this may indicate a need for further assessment beyond the scope of a lubricant.

Therapeutic Uses of Hipromelosa

What Hipromelosa Treats: Main Uses and Benefits

Hipromelosa is primarily used for the symptomatic management of conditions associated with tear film instability, known generally as dry eye syndrome. The preparation works to help ease discomfort and protect the eye's surface by reducing common symptoms such as the feeling of grittiness, burning, or irritation. It is also indicated for situations where symptoms are aggravated by environmental factors, including exposure to wind, sun, or dry air, and following extended periods of screen use.

This medication may also be applied to help provide extended comfort and hydration for individuals using contact lenses. Furthermore, its use is sometimes recommended for the moistening and protective care of the eyes after certain diagnostic or surgical procedures.


Quick Fact: Relief for Ocular Dryness and Discomfort

Eligibility and Restrictions for Use

The official regulatory profile for Hipromelosa (Hypromellose Ophthalmic Solution) is defined by its role as an inert ocular lubricant with negligible systemic absorption. Eligibility is determined primarily by documented contraindications and specific excipient-based restrictions.

Category Official Regulatory Statement
Populations for whom use is contraindicated Patients with known Hypersensitivity (allergy) to the active substance (Hypromellose) or to any of the excipients in the formulation.
Age-related eligibility rules Use is established for Adults and Older Adults. Use is often specified for Children and Infants of all age groups in some documents; however, some labels state safety and efficacy have not been established in those under 18 years.
Pregnancy and lactation eligibility status No effects are anticipated during pregnancy or breastfeeding due to the negligible systemic exposure of the inert substance.
Eligibility-related restrictions Formulations containing Benzalkonium Chloride must not be used while wearing soft contact lenses; lenses must be removed before use and reinserted after a minimum of 15 minutes. Caution is advised for patients with a compromised cornea.

The eligibility profile is structured around the absolute prohibition of hypersensitivity. Due to the negligible systemic absorption, regulatory documents generally allow use across all age groups and do not document restrictions for systemic conditions like renal or hepatic impairment. Restrictions primarily concern the interaction between the preservative and contact lenses.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents define the interaction profile for Hipromelosa (Hypromellose) ophthalmic solution as being focused entirely on physical administration interference with other topical eye medications. The active substance, Hypromellose, is a pharmacologically inert polymer that is not systemically absorbed, meaning interactions involving metabolic enzymes, drug transporters, food, or alcohol are not documented in official labeling.


Interaction Scope

Category Official Regulatory Statement
Medicinal product categories with documented interactions Other topical ophthalmic products (e.g., eye drops, eye ointments).
Mechanistic basis of interactions Physical administration interference. The viscous nature may prolong contact time or block the distribution of subsequently administered substances.
Timing-based interaction rules Co-administration must be separated by a specific time interval (typically at least five minutes) to prevent physical interference with the co-administered drug's absorption.
Interaction-related restrictions Required separation of administration timing when used with any other topical eye medication.

Resulting Interaction Structure

Official interaction statements confirm that Hipromelosa is not documented to interact with systemic medicines, food, or alcohol. The only necessary constraint established by regulatory documents is the mandatory timing-based separation when other ophthalmic drugs are used. This procedural requirement is designed to mitigate the physical interaction and ensure proper ocular exposure for the co-administered medication.

Mechanism of Action

Hipromelosa is a semisynthetic polymer classified as a cellulose ether. The molecule's mechanism of action is primarily physicochemical and involves modification of the tear film layer. The polymer’s structure, defined by its specific molecular weight and degree of hydroxyl substitution, confers high water-binding capacity upon topical application. This physical characteristic allows the formulation to function as a viscosity-modifying agent within the ocular preparation.

This action increases the residence time of the formulation on the corneal and conjunctival epithelia, which is the principal target tissue. Increased retention leads to a direct reduction in the coefficient of friction at the corneal-palpebral interface. Furthermore, the molecule modifies the viscoelastic properties of the tear film and increases the contact angle of the fluid on hydrophobic surfaces, thereby enhancing the overall surface tension properties. The mechanism-of-action is strictly restricted to this physiological modulation of the tear film layer's biophysical characteristics.

Dosage and Administration Information

Administration and Dosing Instructions (Topical Ophthalmic)

Hipromelosa (hydroxypropyl methylcellulose) is administered topically to the eye. Dosage and administration procedures are governed by official guidelines for both over-the-counter (OTC) and prescription formulations.


Official Dosing Schedule

Formulation Dosing Frequency
OTC Eye Drops (e.g., 0.7% solution) Instill 1 to 2 drops in the affected eye, as needed.
Prescription Solution (e.g., Oxervate) Instill one drop in the affected eye(s), 6 times a day at 2-hour intervals for eight weeks.

Procedural Requirements

1. Preparation: Always wash hands before handling the product. For a specific prescription solution (e.g., Oxervate), the vial must be thawed for up to 30 minutes at room temperature (up to 77 F or 25 C) before use, and the vial must not be shaken. The prescription product also requires connecting a vial adapter and using a new, sterile pipette for each of the six daily administrations.

2. Administration: Tilt the head back, form a pouch by pulling the lower eyelid away from the eye, and drop the medicine into the pouch. To maintain sterility, do not touch the applicator tip to the eye or any surface. After instillation, gently close the eyes and do not blink for 1 to 2 minutes to allow for absorption.

3. Missed Dose and Concomitant Use: If a dose is missed, treatment should be continued as normal at the next scheduled time; do not take an extra dose to compensate. If using other topical ophthalmic products, administer the eye drops at least 15 minutes apart to prevent dilution. Contact lenses must be removed prior to application and may be reinserted 15 minutes after the dose is administered.

Recent Clinical Evidence

Research evidence / Overview of studies for Hipromelosa

Hypromellose (Hipromelosa) was studied in research contexts involving conditions characterized by outcomes related to physical discomfort, often resulting from conditions marked by functional limitations such as a deficient tear film. Research primarily consists of short-term Randomized Controlled Trials (RCTs) and systematic reviews that have explored the effects of ophthalmic lubricants on dry eye symptom patterns. These studies have applied in research contexts involving fluctuating or unstable symptoms, using validated scales like the Ocular Surface Disease Index (OSDI) to measure patient-reported outcomes describing perceived discomfort such as dryness, grittiness, and burning. The findings describe patterns observed in the studies where participants using Hypromellose preparations reported changes measured during the study period, with some studies describing a pattern of changes in symptom scores in the observed populations. Findings related to objective clinical signs (like staining) have been limited and heterogeneous, and the certainty regarding changes in the physical signs of the eye remains low in general systematic reviews.


Evidence for Lubrication in Contact Lens Wear

Research has examined the use of solutions containing Hypromellose among adults who wear contact lenses and experience discomfort. These trials studied for the effects on contact lens tolerability and patient-reported outcomes describing perceived discomfort. The studies reported data show patterns related to contact lens tolerability outcomes, particularly in short-term research scenarios. The evidence quality for subjective comfort and tolerability is classified as moderate. However, the research often evaluates the complete solution containing Hypromellose rather than isolating the effect of the single ingredient.


What Is Still Uncertain About Hypromellosa Research

In addition to the limited information for long-term outcomes, comparative evidence is lacking in high-quality trials directly comparing Hypromellose against all currently available alternative lubricants, making detailed comparisons difficult to draw. The follow-up durations were limited, and the long-term effects are not fully established regarding the consistency or durability of reported symptomatic patterns beyond the short-term study intervals. Furthermore, data for certain groups remain insufficient, especially for those with severe forms of dry eye disease, where research has been limited. Dedicated research focusing on pediatric populations (children and adolescents) is limited.

Key Studies & References Label: SPLASH TEARS- hypromellose solution/ drops (Example of a US OTC Drug Label used to confirm regulatory classification and indications)

Frequently Asked Questions (FAQ)

Common questions about Hipromelosa (FAQ)

Q: How long does the moisturizing effect of Hipromelosa typically last?

A: Hipromelosa works by modifying the thickness of the tear film. Official documents describe that this viscosity-promoting property is intended to support the moisturizing effect by prolonging the retention time of the solution on the eye surface. The general labeling, however, does not typically specify an exact duration of effect in hours.

Q: Can Hipromelosa be used while wearing hard contact lenses?

A: Official product information indicates that formulations containing Hipromelosa may be used to moisten hard contact lenses. The directions for use include taking care not to float the lens off the eye during application. This guidance is distinct from the rules for soft contact lenses, which require removal prior to use.

Q: How long after opening the bottle should Hipromelosa be discarded?

A: To maintain sterility and safety, multi-dose bottles of Hipromelosa must be discarded 28 days after first opening, even if solution remains. Single-use vials are often preservative-free and are intended to be discarded after use, as they contain no preservative.

Q: Can children generally use Hipromelosa for dry eyes?

A: Official labeling for Hipromelosa indicates that the recommended use and dosage for children is generally the same as for adults. Official documents state that the medicine is not generally expected to cause different side effects or problems in children compared to those experienced by adults.

Q: Is Hipromelosa sold under different brand names, and are they all the same?

A: The active substance, Hypromellose, is available under many different brand names. While the active ingredient is the same, formulations can contain different concentrations and varying inactive ingredients (excipients). These variations may be relevant to factors like compatibility with contact lenses.

Q: How quickly does Hipromelosa usually start working to relieve dry eyes?

A: According to the product indication text, Hypromelosa eye drops are generally associated with immediate relief for dry eyes upon application. Transient blurred vision is listed as a potential effect shortly after instillation.

Q: Is Hipromelosa the same ingredient as hydroxypropyl methylcellulose (HPMC)?

A: Yes, regulatory authorities have harmonized the name of the active substance. Hypromellose (Hipromelosa) is the established name for the ingredient that was formerly referred to as hydroxypropyl methylcellulose (HPMC).

Q: Does using Hipromelosa affect the results of common eye exams?

A: Official labeling states that Hipromelosa may be used in certain eye examinations or procedures. Its lubricating and viscosity properties can help facilitate the viewing of the cornea or moisten the eye surface during the testing process.

Q: Is Hipromelosa safe to use for an extended period of time?

A: The active substance, Hypromellose, is a pharmacologically inert polymer. Its structure is consistent with a substance having negligible systemic exposure. However, regulatory documents note that long-term research regarding the product’s effect consistency and durability beyond short-term study intervals is limited.

Q: Is there a concentration (e.g., 0.3% vs 0.5%) that is generally preferred or used for different conditions?

A: Regulatory standards generally recognize concentrations between 0.2% and 2.5% as safe and effective for use as an ocular lubricant. Labeling may indicate that certain temporary effects, such as a sensation of stickiness, may be reported more commonly with higher concentration formulations.

Q: What should be done if Hipromelosa does not seem to be helping my dry eye symptoms?

A: Regulatory guidance indicates that if your dry eye condition worsens or persists for more than 72 hours of use, or if you experience associated symptoms such as eye pain or a change in vision, the product use should be discontinued and consultation with a healthcare professional sought.

Q: Does Hipromelosa have any non-ophthalmic uses described in regulatory information?

A: Yes. Beyond its use in eye drops, the substance Hypromellose is recognized by regulatory bodies as generally safe for use as a component in some oral capsule shells and as a food additive.

Q: Is it common to feel a mild stinging or burning sensation when first using Hipromelosa?

A: Official product information states that a mild, temporary stinging, burning, or irritation may occur upon the initial use of the drops. This is listed as a potential transient reaction.

Q: Is there a risk of eye infection from using the eye drops?

A: Contaminated ophthalmic products pose a heightened risk of eye infections. For this reason, regulatory warnings emphasize procedural steps, such as not touching the dropper tip, and the product should be discarded if it appears cloudy or the container is compromised.

Q: Does Hipromelosa have a specific purpose in certain types of eye surgery?

A: Yes, Hypromellose is approved for use as a surgical aid in certain intraocular procedures. This includes surgeries such as cataract removal and lens implantation, where it is used to support the maintenance of the eye’s shape and protect tissues.

Q: Is the medication harmful if accidentally swallowed?

A: Official instructions on the Over-the-Counter (OTC) label advise that if the medicine is accidentally swallowed, immediate medical attention or contact with a poison control center be sought.

Q: Are there official statements regarding Hipromelosa's use with soft contact lenses?

A: Yes. Official warnings state that formulations containing the preservative benzalkonium chloride must not be used while wearing soft contact lenses. Lenses must be removed prior to application and official instructions indicate they may be reinserted 15 minutes after the drops are administered.

Q: What are the general expectations for improvement when using Hipromelosa?

A: Improvement is generally addressed in the short term within regulatory guidance. This guidance advises patients that product use should be discontinued and consultation sought if symptoms persist or worsen after 72 hours of use.

Q: Does Hipromelosa help with eye redness?

A: Hipromelosa is primarily indicated for lubrication and dryness relief. Official safety profiles note that eye redness (ocular hyperaemia) is listed as a potential, though infrequent, adverse reaction. Official documents classify continued redness as a symptom requiring consultation with a healthcare professional.

Q: Is it necessary to shake the bottle before using certain Hipromelosa drops?

A: Instructions for specific formulations, such as certain prescription solutions, state that the vial must not be shaken prior to use. General preparation instructions for other non-prescription formulations do not typically include a shaking requirement.

Q: What happens if I miss a typical application of Hipromelosa?

A: For fixed-schedule dosing, regulatory instructions advise that if a dose is missed, treatment should be continued as normal at the next scheduled time. Users should not take an extra dose to compensate.

Q: Why are single-dose units sometimes recommended over multi-dose bottles?

A: Single-dose units are often preservative-free. This is generally noted as beneficial because the preservative found in multi-dose bottles (such as benzalkonium chloride) may accumulate on soft contact lenses or potentially cause irritation with prolonged use on a compromised corneal surface.

Q: Can a person be eligible to use Hipromelosa if they have certain pre-existing eye conditions?

A: Eligibility is wide, but caution is advised in patients with certain pre-existing eye conditions. Specifically, regulatory documents recommend caution in patients with compromised corneal surfaces or severe dry eye conditions, especially with prolonged use of preserved solutions.

Q: Are there any reported interactions between Hipromelosa and alcohol or tobacco?

A: Due to the active substance being a pharmacologically inert polymer that is not systemically absorbed into the bloodstream, official labeling states that interactions involving metabolic enzymes, drug transporters, food, or alcohol are not documented.

Q: Do the side effects of Hipromelosa differ between children and adults?

A: Official regulatory documents indicate that the medicine is not expected to cause different side effects or problems in children compared to those experienced by adults. The general safety profile is considered consistent across age groups.

Q: Is Hipromelosa used for conditions other than dry eye relief, such as during eye examinations?

A: Yes, Hypromellose is approved for use as a surgical aid in certain intraocular procedures and may also be used to facilitate or protect the eye during certain eye examinations.

How should Hipromelosa be stored and disposed of?

How to Store and Dispose of Hipromelosa — Official Regulatory Information

Hipromelosa (Hypromellose) ophthalmic solution must be stored and handled according to specific official labeling requirements to ensure stability and safety.

Storage & Stability Requirement Official Constraint
Temperature & Light Store the product below 25 C and protect from light. Do not freeze.
In-Use Stability Discard the bottle 28 days after first opening, even if solution remains.
Packaging Keep the container tightly closed and in the original outer carton to maintain sterility and protection.
Child Safety Keep the medicine out of the sight and reach of children.

Disposal Requirements

Disposal of unused or expired Hipromelosa must be conducted in accordance with local requirements for pharmaceutical waste. Regulatory documents explicitly advise against throwing away medicines via wastewater or household waste. Consult a pharmacist or local waste disposal company for collection programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Hipromelosa found in:

A-Z Index: